Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, ...

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced Biafine® Skin Recovery Emulsion is now offered through convenient online ordering in ...

Bausch + Lomb (BLCO) reported largely in-line fiscal first-quarter financial results before the opening bell Wednesday. The numbers were not a surprise because B+L reported its first quarter results ...

FDA clearance for its Bi-Blade+ advanced dual-port vitrectomy cutter and Adaptive Fluidics update for the Stellaris Elite ...

The Financial Times reported Bausch + Lomb is in talks with advisors to potentially sell itself. It had formerly sought to spin off from parent Bausch Health in a stock-for-stock deal. But Bausch ...

The healthcare sector continues to evolve through advancements in ophthalmology, medical devices, and therapeutic solutions.

Shares of Bausch Health Company (NYSE: BHC) were jumping 4.4% at 10:54 a.m. ET on Wednesday after rising as much as 11.8% earlier in the day. The gain came after the company announced results so far ...

Large financial buyers are looking at the potential opportunity to carve-out Bausch + Lomb – whose activist-pressured parent company announced last year it planned to spin off the iconic eye-health ...

Bausch Health Companies Inc. (NYSE:BHC) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On February 25, Glen Santangelo from Barclays reduced the price target ...

Bausch Health is still in the process of unraveling its Bausch + Lomb segment into a separate eye care company. It said it plans to appeal a court ruling that went against it in a patent fight. Bausch ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ...

Bausch Health Cos. (BHC) reported abysmal first-quarter results before the opening bell Tuesday. Revenue of $1.92 billion, flat year over year on an organic basis, missed expectations of $2.03 billion ...